Clinical Trial Update: Early Feasibility Study to Evaluate the Safety and Efficacy of PAK HD in ESRD Patients [NA]

View source ↗

Summary

Completion of an early feasibility trial evaluating the safety and efficacy of PAK HD in patients with end-stage renal disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• PAK HD

Snippet

Sponsor: Nextkidney S.A. | Conditions: End Stage Renal Disease, ESRD | NA | Status: COMPLETED